Author Summary
SGLT2 Inhibitors Show Stronger Long-Term Blood Sugar Control Than Sulfonylureas
Meta-analysis highlights long-term advantages in type 2 diabetes treatment Type 2 diabetes mellitus (T2DM) is a chronic disease marked by insulin resistance and progressive β-cell decline. As the condition advances, many patients experience rising blood […]